Role of Vitamin D in Uremic Vascular Calcification

Abstract EN

The risk of cardiovascular death is 10 times higher in patients with CKD (chronic kidney disease) than in those without CKD.

Vascular calcification, common in patients with CKD, is a predictor of cardiovascular mortality.

Vitamin D deficiency, another complication of CKD, is associated with vascular calcification in patients with CKD.

GFR decline, proteinuria, tubulointerstitial injury, and the therapeutic dose of active form vitamin D aggravate vitamin D deficiency and reduce its pleiotropic effect on the cardiovascular system.

Vitamin D supplement for CKD patients provides a protective role in vascular calcification on the endothelium by (1) renin-angiotensin-aldosterone system inactivation, (2) alleviating insulin resistance, (3) reduction of cholesterol and inhibition of foam cell and cholesterol efflux in macrophages, and (4) modulating vascular regeneration.

For the arterial calcification, vitamin D supplement provides adjunctive role in regressing proteinuria, reverse renal osteodystrophy, and restoring calcification inhibitors.

Recently, adventitial progenitor cell has been linked to be involved in the vascular calcification.

Vitamin D may provide a role in modulating adventitial progenitor cells.

In summary, vitamin D supplement may provide an ancillary role for ameliorating uremic vascular calcification.